Results 251 to 260 of about 43,549 (263)

Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2016
Robert A Smith, Stacey A Fedewa, Joannie Lortet-Tieulent   +2 more
exaly  

5-lipoxygenase inhibitors for hyperkeratosis

Inpharma Weekly, 1992
openaire   +1 more source

5-Lipoxygenase-Activating Protein Inhibitors

2017
K.A. Heidenreich, C.E. Corser-Jensen
openaire   +1 more source

Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer‐related cognitive impairment in adults

Ca-A Cancer Journal for Clinicians, 2015
Jeffrey S Wefel, Shelli R Kesler
exaly  

Cancer screening, prevention, and treatment in people with mental illness

Ca-A Cancer Journal for Clinicians, 2016
Ana Stefancic, Amy T Cunningham, Richard C Wender   +2 more
exaly  

Cancer screening in the United States, 2014: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2014
Robert A Smith
exaly  

Breast cancer statistics, 2015: Convergence of incidence rates between black and white women

Ca-A Cancer Journal for Clinicians, 2016
Carol E Desantis, Ann Goding Sauer Msph, Robert A Smith   +2 more
exaly  

Cancer screening in the United States, 2015: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2015
Robert A Smith
exaly  

Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2018
Robert A Smith, Stacey A Fedewa, Otis W Brawley   +2 more
exaly  

Development of 5-lipoxygenase inhibitor.

Advances in prostaglandin, thromboxane, and leukotriene research, 1987
M, Toda, H, Nakai, S, Sakuyama, Y, Arai, S, Kaneko, H, Ohno, T, Okegawa   +6 more
openaire   +1 more source